Company: OPKO Health, Inc.
Class Period: September 26, 2013 — September 7, 2018
Court: U.S.D.C. - District of New Jersey
Deadline: November 13, 2018
A shareholder class action complaint has been filed against OPKO Health, Inc. (“OPKO” or the “Company”) (NASDAQ: OPK) on behalf of investors who purchased the Company’s securities between September 26, 2013 through September 7, 2018, inclusive (the “Class Period”).
On September 7, 2018 the U.S. Securities and Exchange Commission (“SEC”) filed a complaint against OPKO and its Chief Executive Officer, Phillip Frost, alleging that they violated the Securities Act of 1933 and Securities Exchange Act of 1934. Specifically, the SEC’s complaint alleged that OPKO and Frost were participants in “highly profitable ‘pump-and-dump’ schemes … from 2013 through 2018” in the stock of public companies that, “while enriching Defendants by millions of dollars, left retail investors holding virtually worthless shares.”
Following this news, shares of OPKO’s common stock declined $1.01 per share, or over 18%, before they were halted for trading by Nasdaq on September 7, 2018 at $4.58 per share.
IMPORTANT DEADLINE: Investors who purchased OPKO’s securities during the Class Period may, no later than November 13, 2018, seek to be appointed as a lead plaintiff of the class.
OPKO investors are encouraged to contact Kaskela Law LLC at (888) 715 – 1740 to discuss this investigation and their legal rights and options and/or complete the information form on this page.